The development of empyema occurs in stages: initially an inflammatory process like pneumonia causes fluid buildup in the pleural cavity known as exudate; bacteria then colonize this fluid, generating an empyema characterized by high levels of proteins, cells and other markers; if not treated, the fluid thickens and becomes opaque as fibrosis develops, restricting lung function.
The development of empyema occurs in stages: initially an inflammatory process like pneumonia causes fluid buildup in the pleural cavity known as exudate; bacteria then colonize this fluid, generating an empyema characterized by high levels of proteins, cells and other markers; if not treated, the fluid thickens and becomes opaque as fibrosis develops, restricting lung function.
The development of empyema occurs in stages: initially an inflammatory process like pneumonia causes fluid buildup in the pleural cavity known as exudate; bacteria then colonize this fluid, generating an empyema characterized by high levels of proteins, cells and other markers; if not treated, the fluid thickens and becomes opaque as fibrosis develops, restricting lung function.
The development of empyema can be described in a sequence of events. During an inflammatory
process such as pneumonia, there is an increase in fluid production in the pleural cavity known as the exudate stage. As the disease progresses microorganisms, usually bacteria, can colonize the fluid and generated an empyema. This fluid is characterized by elevated lactate dehydrogenase, proteins, neutrophils, and dead cells. Macroscopically is a thick opaque fluid found in the fibrinopurulent stage. After the resolution of the infection and as a consequence of the inflammation, there is a process of fibrosis that can lead to restriction of the lung parenchyma. Appropriate and early intervention is vital to decrease complications and mortality.[